Carlson Capital’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Carlson Capital’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,300,000	Closed	-$274K	–	166
2023 Q2	$274K	Buy	1,300,000 +300,000	+30%	+$52.1K	0.02%	116
2023 Q1	$160K	Buy	+1,000,000	New	+$444K	0.02%	110

Other funds holding INFI

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Carlson Capital's INFI Position: Q3 2023 in Review

Carlson Capital sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 1,300,000 shares — an estimated $274K sold.

Carlson Capital first reported a position in INFI in Q1 2023 and held it in 2 quarters. The position peaked at $274K in Q2 2023. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

Carlson Capital reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Carlson Capital sold 1,300,000 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $274K.
Carlson Capital first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2023 and held it in 2 quarters.
Carlson Capital's Infinity Pharmaceuticals, Inc. position peaked at $274K in Q2 2023.
3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Carlson Capital's 13F filing for Q3 2023, filed 14 Nov 2023.